- Home
- CME
CME
CME Group Inc.
as 06-20-2025 4:00pm EST
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
| Founded: | 1898 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 102.5B | IPO Year: | 2002 |
| Target Price: | $257.88 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Hold | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.94 | EPS Growth: | 13.21 |
| 52 Week Low/High: | $192.10 - $290.79 | Next Earning Date: | 07-23-2025 |
| Revenue: | $6,274,100,000 | Revenue Growth: | 11.73% |
| Revenue Growth (this year): | 9.32% | Revenue Growth (next year): | 4.04% |
Stock Insider Trading Activity of CME Group Inc. (CME)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Carey Charles P | CME | Director | Jun 10 '25 | Sell | $265.36 | 500 | $132,676.50 | 4,900 | |
| Kaye Daniel G | CME | Director | May 22 '25 | Sell | $282.42 | 500 | $141,209.65 | 3,668 | |
| Marcus Jonathan L | CME | Sr MD General Counsel | May 20 '25 | Sell | $277.50 | 390 | $108,225.00 | 6,708 | |
| Lockett Phyllis M | CME | Director | May 19 '25 | Sell | $277.88 | 1,060 | $294,552.80 | 3,108 | |
| GEPSMAN MARTIN J | CME | Director | May 15 '25 | Sell | $273.17 | 300 | $81,951.00 | 24,767 | |
| Carey Charles P | CME | Director | May 15 '25 | Sell | $272.56 | 3,000 | $817,680.00 | 4,900 | |
| Suskind Dennis | CME | Director | Apr 29 '25 | Sell | $271.28 | 1,000 | $271,280.00 | 2,915 |
Latest CME Group Inc. News
CME Breaking Stock News: Dive into CME Ticker-Specific Updates for Smart Investing
Yahoo Finance
19 hours ago
Stock market today: S&P 500, Nasdaq fall amid Fed rate uncertainty as Trump mulls Iran move
Yahoo Finance
a day ago
Stock market today: Dow, S&P 500, Nasdaq rise with Trump's Iran decision, Fed rate cuts in focus
Simply Wall St.
3 days ago
CME Group (NasdaqGS:CME) Introduces E-Mini Futures For Mexico's S&P BMV IPC Index
GlobeNewswire
3 days ago
US Financial 15 Split Corp. Preferred Dividend Declared
PR Newswire
4 days ago
CME Group Inc. Announces Second-Quarter 2025 Earnings Release, Conference Call
Zacks
4 days ago
3 Bitcoin-Centric Stocks in Focus Amid Ongoing Geopolitical Tensions
PR Newswire
4 days ago
CME Group to Launch Futures on Mexico's IPC Index
Zacks
10 days ago
The Zacks Analyst Blog Highlights PayPal, Visa and CME
Compare CME vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CME CME Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.